Sotuvning sof marjinal rentabelligi: Pacific Biosciences of California (PACB)

PacBio Corp - PACB emitenti grafik logotipi

Pacific Biosciences sekvensirlash asboblarini yig'ish uchun AQShda steril zavodlar va R&D markazlarini boshqaradi. Daromadlar yuqori aniqlikdagi tizimlar, dasturiy ta'minot va sarf materiallarining sotuviga asoslangan. Biznesning sof marja samaradorligi foyda dinamikasini namoyish etadi, bunda -81.30 joriy metrika ko'rsatkichi hisoblanadi. Shu bilan birga, kompaniya o'z laboratoriyalari bo'ylab plastik chiqindilarni kamaytirmoqda va energiya xarajatlarini optimallashtirmoqda.

PacBio Corp (PACB) - Kompaniya sotuv marjasi 04.07.2022dan 19.11.2026gacha

Pacific Biosciences of California (PACB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning asosiy tahlili:PacBio Corp - PACB
Pacific Biosciences of California, Inc. ishlab chiqargan mahsulot

Pacific Biosciences (PACB) kompaniyasining robotlashtirilgan liniyalar va mashina ko'rish texnologiyalaridan foydalangan holda DNK sekvensirlash tizimlarini yuqori texnologik ishlab chiqarishi sezilarli kapital xarajatlarni talab qiladi. Sof marja barcha xarajatlardan keyin qolgan daromad qismini belgilaydi, bu esa investorga biznesning sof marginal samaradorligini tahlil qilish orqali har bir mahsulot birligining haqiqiy daromadliligini baholash, sikl bosqichlarini va kelgusidagi korreksiya xavflarini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX